13-oxo-9,11-octadecadienoic acid has been researched along with isoliquiritigenin in 1 studies
Studies (13-oxo-9,11-octadecadienoic acid) | Trials (13-oxo-9,11-octadecadienoic acid) | Recent Studies (post-2010) (13-oxo-9,11-octadecadienoic acid) | Studies (isoliquiritigenin) | Trials (isoliquiritigenin) | Recent Studies (post-2010) (isoliquiritigenin) |
---|---|---|---|---|---|
5 | 0 | 5 | 472 | 2 | 324 |
Protein | Taxonomy | 13-oxo-9,11-octadecadienoic acid (IC50) | isoliquiritigenin (IC50) |
---|---|---|---|
Estrogen receptor | Homo sapiens (human) | 1.87 | |
Interstitial collagenase | Homo sapiens (human) | 0.016 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 0.269 | |
72 kDa type IV collagenase | Homo sapiens (human) | 0.01 | |
Stromelysin-1 | Homo sapiens (human) | 0.081 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.269 | |
Matrilysin | Homo sapiens (human) | 0.008 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.269 | |
Aromatase | Homo sapiens (human) | 3.8 | |
17-beta-hydroxysteroid dehydrogenase type 1 | Homo sapiens (human) | 2.83 | |
Matrix metalloproteinase-9 | Homo sapiens (human) | 0.01 | |
Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 0.32 | |
Proteasome subunit beta type-5 | Homo sapiens (human) | 4.88 | |
17-beta-hydroxysteroid dehydrogenase type 2 | Homo sapiens (human) | 0.36 | |
Collagenase 3 | Homo sapiens (human) | 0.014 | |
Estrogen receptor beta | Homo sapiens (human) | 0.269 | |
NACHT, LRR and PYD domains-containing protein 3 | Homo sapiens (human) | 1.54 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kishore, N; Kumar, P; Shanker, K; Verma, AK | 1 |
1 review(s) available for 13-oxo-9,11-octadecadienoic acid and isoliquiritigenin
Article | Year |
---|---|
Human disorders associated with inflammation and the evolving role of natural products to overcome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biological Products; Cardiovascular Diseases; Humans; Inflammation; Neoplasms; Skin Diseases | 2019 |